Brandon Tom

P

President & Chief Executive Officer

Dec 2022 - Current (3 years 7 months)

Orsini is on a mission to partner with biopharma innovators, healthcare providers and payers to support patients and their families in accessing revolutionary treatment for rare diseases. Through our integrated portfolio of services, we simplify how patients connect to advanced therapies and provide holistic, compassionate care.

General Manager

Biologics by McKesson

Jun 2020 - Nov 2022 (2 years 6 months)

Full P&L responsibility for the Biologics by McKesson business. Lead teams responsible for growth (sales, marketing, strategy), operations (pharmacy, call center, biopharma-sponsored “hubs”, quality assurance, training), managed care contracting, clinical services, finance and legal. Biologics is a $3B, 400+ employee specialty pharmacy and patient services company, focused in the oncology and rare disease markets, acquired by McKesson in April 2016.

V

Vice President, Chief Commercial Officer

Nov 2016 - May 2020 (3 years 7 months)

Post acquisition, replaced the company’s Chief Commercial Officer to lead a 75+ employee team responsible for the customer-facing, growth functions of the organization, including business development with biopharma manufacturers, provider sales, sales enablement, account management, marketing and strategy. Primary focus was to partner with life science / pharma companies to provide guidance and support the commercialization of their specialty therapies by creating customized solutions for pharmacy distribution, access, adherence and third party logistics (3PL).

Vice President, Oral Oncology Products & Services

The US Oncology Network

Oct 2013 - Oct 2016 (3 years 1 month)

Responsibility for the oral oncology segment of the US Oncology’s practice management services and McKesson Specialty Health’s distribution portfolio. Grew business from zero to $1 billion in revenue in four years by building 100+ medically integrated pharmacies within our community cancer centers. Led a team of 30+ employees focused on pharmaceutical trade and sourcing activities, pharmacy build-out and operations, sales and account management and payer strategy. Served as internal thought leader to our Onmark and Unity GPO teams.

Director, Corporate Strategy & Business Development - Community Oncology

McKesson

Jun 2012 - Sep 2013 (1 year 4 months)

Primary focus was to identify opportunities within the community oncology market. With a $500K investment, led the development and launch of a start-up business focused on driving oncology providers to start in-office specialty pharmacies, enabling them to dispense oral medications to their patients and opening a distribution channel for McKesson. Led all aspects of the business - sales, pricing, marketing, pharmacy implementations and manufacturer relations to ensure distribution access and GPO economics for our customers. In six months, the business generated over $100M in revenue, became EBITDA positive and was the fastest growing business in the organization.

Senior Manager, Corporate Strategy & Business Development - Value-Based Care

McKesson

Apr 2011 - May 2012 (1 year 2 months)

Evaluated growth opportunities, both organic and M&A, across our pharmaceutical distribution and healthcare technology divisions. Primary focus was on the enterprise-wide Accountable Care Organization (ACO) and value-based care strategy, where I collaborated across business units to develop a go-to-market strategy (marketing, pricing, sales) for a turn-key technology platform enabling IDN’s to better manage high-risk populations. Key member of the due diligence team for MedVentive acquisition, a leading provider of SaaS-based population and risk-management solutions.

M

Manager, GPO and Payer Services

McKesson Specialty Care Solutions

Jul 2008 - Mar 2011 (2 years 9 months)

Responsible for managing biopharma relationships and negotiating GPO agreements to improve drug purchasing economics for physician membership. Additionally, supported the development of a payer strategy for community oncology practices focused on creating clinical pathways to negotiate value-based care arrangements with national health plans and was the product manager of Regimen Profiler®, a web-based application for physician practices to forecast the cost-effectiveness of therapy regimens.

Associate, Pharmacy Benefit Management

Health Net

Jul 2007 - Jun 2008 (1 year)

As an associate in Health Net’s managed care pharmacy residency program, I developed and implemented a new and more efficient formulary decision-making process which better integrated analytics, financial models and rebate-contracting.

About

Detail

Timeline

Résumé